[SRNE] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 35.93%
YoY- -239.37%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 6,477 6,143 6,929 4,105 3,913 6,246 20,407 -53.56%
PBT -70,654 -145,810 -55,746 -50,380 -74,081 -33,574 -38,001 51.37%
Tax -383 -178 -3,122 -826 -1,377 -948 -90,424 -97.40%
NP -56,762 -108,071 -49,776 -47,328 -73,864 -32,574 12,425 -
Tax Rate - - - - - - - -
Total Cost 63,239 114,214 56,705 51,433 77,777 38,820 7,982 298.92%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -876.36 -1,759.25 -718.37 -1,152.94 -1,887.66 -521.52 60.89 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.46 -0.88 -0.41 -0.40 -0.73 -0.38 0.15 -
EPS Diluted -0.43 -0.88 -0.41 -0.40 -0.73 -0.38 0.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.